trial
as of 2026-07-01Antipsychotics and Gene Expression in Soft Tissues
NCTId NCT01185743
at a glance
Phase 4 · Completed
Enrollment 16 (actual)
Sponsored by Medical University of Vienna
Primary completion 2017-01-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
16 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2010-07
Primary completion
2017-01-01
Eligibility
MALE · 18 Years · 45 Years
Interventions & indications
Sponsors
Medical University of ViennaLead Sponsor
Investigators
1
Martin Brunner, MDPrincipal Investigator
Sites
1 total
Vienna, Austria
Facts & assertions
4 sourced
Enrollment
16
Phase
PHASE4
Primary Completion Date
2017-01-01
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
company
indication
investigator
person